申请人:TANIGUCHI Takahiko
公开号:US20110319394A1
公开(公告)日:2011-12-29
The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I):
wherein the symbols are defined in the specification.
本发明提供了一种具有磷酸二酯酶抑制作用的化合物,可用作预防或治疗精神分裂症的药剂。该化合物由以下式表示(I):
其中符号在规范中定义。